{
    "clinical_study": {
        "@rank": "111128", 
        "arm_group": [
            {
                "arm_group_label": "Clomiphene citrate", 
                "arm_group_type": "Active Comparator", 
                "description": "Clomiphene citrate 25 mg every other day during 4-6 months"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo every other day during 4-6 months"
            }
        ], 
        "brief_summary": {
            "textblock": "Hypothesis: Prescribed clomiphene citrate to azoospermic patients with hypoandrogenism could\n      improve the sperm retrieval in either fresh sperm or after surgical sperm extraction."
        }, 
        "brief_title": "Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Non Obstructive Azoospermia", 
            "Hypogonadism"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Azoospermia", 
                "Hypogonadism"
            ]
        }, 
        "detailed_description": {
            "textblock": "Hypogonadism (low testosterone level) is frequently observed in men presenting with non\n      obstructive azoospermia. Controversy exists regarding the efficacy of preoperative hormonal\n      manipulation in patients with  hypogonadism. However, it is possible that hormonal therapy\n      increases intra-testicular testosterone levels, and with a rise in serum testosterone, sperm\n      production and surgical success with microTESE improve."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18 years old\n\n          -  Azoospermia confirmed in at least 2 semen analyses with centrifugation.\n\n          -  Testosterone <300 ng/dL and Bioavailable Testosterone<156 ng/dL.\n\n        Exclusion Criteria:\n\n          -  Presence of genetic disorders: Y chromosome deletions or abnormal karyotypes.\n\n          -  Luteinizing hormone (LH) >25 IU/mL.\n\n          -  Estradiol > 40 ng/dL.\n\n          -  Hypogonadotropic hypogonadism  (LH <2 IU/mL and Follicle Stimulating Hormone (FSH) <1\n             IU/mL).\n\n          -  Obstructive azoospermia:\n\n          -  FSH <7.6 IU/mL plus testicle longitudinally axis >4.6 cm.\n\n          -  Bilateral absence of vas deferens.\n\n          -  Surgical history of vasectomy.\n\n          -  Clinical varicocele (palpable or visible in physical exam)\n\n          -  Previous history of cryptorchidism.\n\n          -  Use of chemotherapy, testosterone, or anti-androgen in the last two years. Partner\n             >40 years or female factor infertility associated.\n\n          -  Contraindications to clomiphene use: depression, heart and liver impairment,\n             uncontrolled    thyroid/adrenal dysfunction, organic intracranial lesions."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "158", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02137265", 
            "org_study_id": "2014-0343"
        }, 
        "intervention": [
            {
                "arm_group_label": "Clomiphene citrate", 
                "description": "Clomiphene citrate 50 mg orally every other day", 
                "intervention_name": "Clomiphene", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Clomid", 
                    "Serophene"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "One pill every other day", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "control"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Clomiphene"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Azoospermia", 
            "Hypogonadism", 
            "Clomiphene"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "contact": {
                "email": "craignied@gmail.com", 
                "last_name": "Craig Niederberger, MD, FRCS", 
                "phone": "312-996-9330"
            }, 
            "contact_backup": {
                "email": "satlujan@gmail.com", 
                "last_name": "Satur Luj\u00e1n, MD, PhD", 
                "phone": "3129969330"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60612"
                }, 
                "name": "University of Illinois"
            }, 
            "investigator": {
                "last_name": "Satur Luj\u00e1n, MD, PhD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-blind, Placebo-controlled Trial of Clomiphene Citrate of Clomiphene Citrate in Hypoandrogenism and Azoospermia", 
        "other_outcome": {
            "description": "Identification of at least 1 gestational sac with a fetal heartbeat by transvaginal ultrasound examination", 
            "measure": "Clinical pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "6-7 weeks after embryo transfer"
        }, 
        "overall_contact": {
            "email": "satlujan@gmail.com", 
            "last_name": "Luj\u00e1n Satur, MD, PhD", 
            "phone": "3129969330"
        }, 
        "overall_contact_backup": {
            "email": "craignied@gmail.com", 
            "last_name": "Niederberger Craig, MD, FRCS", 
            "phone": "3129969330"
        }, 
        "overall_official": {
            "affiliation": "Department of Urology, UIC College of Medicine", 
            "last_name": "Craig Niederberger, MD, FRCS", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Spain: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Presence of sperm in the ejaculated or in the microsurgical testicular Sperm extraction (microTESE)", 
            "safety_issue": "No", 
            "time_frame": "After four months of clomiphene treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02137265"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Illinois at Chicago", 
            "investigator_full_name": "Dr. Craig Niederberger", 
            "investigator_title": "Clarence C. Saelhof Professor and Head, Department of Urology, UIC College of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "16291975", 
                "citation": "Hussein A, Ozgok Y, Ross L, Niederberger C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl. 2005 Nov-Dec;26(6):787-91; discussion 792-3."
            }, 
            {
                "PMID": "22958644", 
                "citation": "Hussein A, Ozgok Y, Ross L, Rao P, Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU Int. 2013 Mar;111(3 Pt B):E110-4. doi: 10.1111/j.1464-410X.2012.11485.x. Epub 2012 Sep 7."
            }
        ], 
        "secondary_outcome": {
            "measure": "Testosterone levels and Bioavailable Testosterone levels", 
            "safety_issue": "No", 
            "time_frame": "After two weeks and four months with clomiphene treatment"
        }, 
        "source": "University of Illinois at Chicago", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Hospital Universitario La Fe", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Instituto Valenciano de Infertilidad, Spain", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University College London Hospitals", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Illinois at Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}